Temporal arteritis MRI
|
Temporal Arteritis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Temporal arteritis MRI On the Web |
|
American Roentgen Ray Society Images of Temporal arteritis MRI |
|
Risk calculators and risk factors for Temporal arteritis MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
There are no diagnostic MRI findings associated with temporal arteritis. However, a MRI with gandolium contrast may be helpful in the diagnosis of complications of temporal arteritis, which include loss of the normal flow in affected vessels from occlusion, slow flow through the vessel, stenoses, irregularity of the vessel wall, and beading or thickening of the vessel.
MRI
There are no diagnostic MRI findings associated with temporal arteritis. However, a MRI with gandolium contrast may be helpful in the diagnosis of complications of temporal arteritis, which include:[1][2][3][4]
- Loss of the normal flow in affected vessels from occlusion
- Slow flow associated with disease
- Stenoses
- Irregularity of the vessel wall
- Beading or thickening of the vessel
References
- ↑ Anders HJ, Sigl T, Sander A, Coppenrath E, Pfluger T, Kellner H (1999). "Gadolinium contrast magnetic resonance imaging of the temporal artery in giant cell arteritis". J Rheumatol. 26 (10): 2287–8. PMID 10529164.
- ↑ Bley TA, Uhl M, Carew J, Markl M, Schmidt D, Peter HH; et al. (2007). "Diagnostic value of high-resolution MR imaging in giant cell arteritis". AJNR Am J Neuroradiol. 28 (9): 1722–7. doi:10.3174/ajnr.A0638. PMID 17885247.
- ↑ Khoury JA, Hoxworth JM, Mazlumzadeh M, Wellik KE, Wingerchuk DM, Demaerschalk BM (2008). "The clinical utility of high resolution magnetic resonance imaging in the diagnosis of giant cell arteritis: a critically appraised topic". Neurologist. 14 (5): 330–5. doi:10.1097/NRL.0b013e3181836add. PMID 18784606.
- ↑ D'Souza NM, Morgan ML, Almarzouqi SJ, Lee AG (2016). "Magnetic resonance imaging findings in giant cell arteritis". Eye (Lond). 30 (5): 758–62. doi:10.1038/eye.2016.19. PMC 4869132. PMID 26915748.